Market closedNon-fractional

OptiNose/OPTN

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About OptiNose

OptiNose Inc is a specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. Its product includes XHANCE (fluticasone propionate) nasal spray, 93 micrograms, a therapeutic utilizing its proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids.

Ticker

OPTN

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Yardley, United States

Employees

132

OptiNose Metrics

BasicAdvanced
$151M
Market cap
-
P/E ratio
-$0.27
EPS
-0.10
Beta
-
Dividend rate
$151M
-0.1
1.579
1.579
-132.759
-133.49
-0.67%
-10.36%
35.49%
1.578
-1.19
-1.19
-3.601
0.90%
-62.78%
11.07%
-47.94%

What the Analysts think about OptiNose

Analyst Ratings

Majority rating from 4 analysts.
Buy

OptiNose Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-94.59% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15M
-25.25%
Net income
-$14M
41.41%
Profit margin
-94.59%
89.18%

OptiNose Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 11.63%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.02
-$0.08
-$0.09
-$0.12
-
Expected
-$0.11
-$0.09
-$0.09
-$0.11
-$0.08
Surprise
-118.43%
-15.19%
-4.59%
11.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for OptiNose stock?

OptiNose (OPTN) has a market cap of $151M as of July 06, 2024.

What is the P/E ratio for OptiNose stock?

The price to earnings (P/E) ratio for OptiNose (OPTN) stock is 0 as of July 06, 2024.

Does OptiNose stock pay dividends?

No, OptiNose (OPTN) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next OptiNose dividend payment date?

OptiNose (OPTN) stock does not pay dividends to its shareholders.

What is the beta indicator for OptiNose?

OptiNose (OPTN) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.

Buy or sell OptiNose stock

Buy or sell OptiNose stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing